NewsBenzingaFoghorn Therapeutics cambia su estrategia de desarrollo tras poner fin al acuerdo con Eli Lilly Foghorn Therapeutics cambia su estrategia de desarrollo tras poner fin al acuerdo con Eli Lilly Benzinga 2026.10.01 16:17 (GMT+0) Open on Benzinga Other news AppLovin Stock Falls to 52-Week Low: What's Happening? 'Barbie-Maker Mattel Draws Takeover Interest from Authentic Brands Group'- WSJ Apple To $355? Here Are 10 Top Analyst Forecasts For Thursday Anthropic Introduces Mods, Small TypeScript Functions That Change How Claude Code Works 'Boeing adds to big week with first full-rate Grey Wolf helicopter order'- DefenseNews Constellium: The Spread Between Feedstock And End Prices Keeps Widening (NYSE:CSTM)
